207 related articles for article (PubMed ID: 12107064)
1. GSK-3beta negatively regulates skeletal myotube hypertrophy.
Vyas DR; Spangenburg EE; Abraha TW; Childs TE; Booth FW
Am J Physiol Cell Physiol; 2002 Aug; 283(2):C545-51. PubMed ID: 12107064
[TBL] [Abstract][Full Text] [Related]
2. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
[TBL] [Abstract][Full Text] [Related]
3. Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors.
Fang CH; Li BG; James JH; King JK; Evenson AR; Warden GD; Hasselgren PO
Endocrinology; 2005 Jul; 146(7):3141-9. PubMed ID: 15802492
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
5. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
Li BG; Hasselgren PO; Fang CH
Int J Biochem Cell Biol; 2005 Oct; 37(10):2207-16. PubMed ID: 15927518
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glycogen synthase kinase 3beta activity regulates proliferation of cultured cerebellar granule cells.
Cui H; Meng Y; Bulleit RF
Brain Res Dev Brain Res; 1998 Dec; 111(2):177-88. PubMed ID: 9838099
[TBL] [Abstract][Full Text] [Related]
8. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity.
Bijur GN; Jope RS
J Neurochem; 2000 Dec; 75(6):2401-8. PubMed ID: 11080191
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.
van der Velden JL; Langen RC; Kelders MC; Wouters EF; Janssen-Heininger YM; Schols AM
Am J Physiol Cell Physiol; 2006 Feb; 290(2):C453-62. PubMed ID: 16162663
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation.
Rössig L; Badorff C; Holzmann Y; Zeiher AM; Dimmeler S
J Biol Chem; 2002 Mar; 277(12):9684-9. PubMed ID: 11779850
[TBL] [Abstract][Full Text] [Related]
11. Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes.
Tang Q; Gonzales M; Inoue H; Bowden GT
Cancer Res; 2001 Jun; 61(11):4329-32. PubMed ID: 11389054
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein beta by modulating Akt and glycogen synthase kinase-3.
Piwien-Pilipuk G; Van Mater D; Ross SE; MacDougald OA; Schwartz J
J Biol Chem; 2001 Jun; 276(22):19664-71. PubMed ID: 11278638
[TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.
Singh LP; Jiang Y; Cheng DW
Int J Biol Sci; 2006 Oct; 3(1):27-39. PubMed ID: 17200689
[TBL] [Abstract][Full Text] [Related]
17. Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.
Kuemmerle JF
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G101-10. PubMed ID: 15297258
[TBL] [Abstract][Full Text] [Related]
18. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
Christian SL; Sims PV; Gold MR
J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
[TBL] [Abstract][Full Text] [Related]
19. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.
Salas TR; Reddy SA; Clifford JL; Davis RJ; Kikuchi A; Lippman SM; Menter DG
J Biol Chem; 2003 Oct; 278(42):41338-46. PubMed ID: 12900420
[TBL] [Abstract][Full Text] [Related]
20. IGF-I activates the mouse type IIb myosin heavy chain gene.
Shanely RA; Zwetsloot KA; Childs TE; Lees SJ; Tsika RW; Booth FW
Am J Physiol Cell Physiol; 2009 Oct; 297(4):C1019-27. PubMed ID: 19657059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
